中国先天性心脏病介入治疗现状

Current status in interventional therapy of congenital heart disease in China

中国每年新出生先天性心脏病(先心病)患儿约15万例。自从1984年在中国开展首例先心病介入治疗以来,随着介入技术的提高、国产器材的应用及经验的不断积累,先心病介入治疗得到了迅速发展。自2009年1月至2012年12月,中国共完成先心病介入治疗81 645例。技术成功率97.69%,严重并发症发生率0.17%,病死率0.03%。目前中国共有33个先心病介入治疗培训基地,在卫生部医政司心血管疾病介入诊疗项目办公室的管理及指导下,先心病介入治疗将日趋规范和普及,使更多的患者获益。

Fifteen hundred thousand infants were born with congenital heart disease （CHD） every year in China. Since the first transcatheter therapy of CHD was performed in China in 1984, with the advancement of interventional techniques, the application of China＇s homemade device and the accumulation of clinical experience, we have achieved great progress in transcatheter therapy of CHD in China. From January 2009 to December 2012, a total of 81 645 patients with CHD were treated by interventional therapy, and the technical success rate was 97. 69%. The severe complication rate was 0. 17% , and the mortality rate was 0. 03%. At present, there are 33 training centers of interventional treatment for congenital heart dis- ease in China. Qualitative surveillance of interventional therapy for CHD has been controlled by the Ministry of Health of the People＇s Republic of China. We believe that the practice of interventional therapy for CHD in China will soon be standard- ized and widely developed in the future, and more and more Chinese patients with CHD will benefit from interventional therapy.